Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Yuh-Lih Chang"'
Autor:
Hsuan-Yu Chang, Chia-Chen Hsu, Li-Fang Hu, Chian-Ying Chou, Yuh-Lih Chang, Chih-Chia Lu, Li-Jen Chang
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Background Literature on the safety of remdesivir in hospitalized COVID-19 patients with severe renal impairment is limited. We aimed to investigate the safety and effectiveness of remdesivir in this population.Methods We conducted a retrospective co
Externí odkaz:
https://doaj.org/article/6fbee71a675346fead6e52707c016bb0
Autor:
Yi-Hsuan Lai, Yi-Chih Lee, I-Ren Chen, Shih-Neng Lin, Yuh-Lih Chang, Chih-Chia Lu, Ping-Feng Wu, Yi-Tsung Lin
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 56, Iss 6, Pp 1207-1213 (2023)
Background: Coronavirus disease-2019 (COVID-19) remains a global public health concern, and remdesivir plus dexamethasone combination therapy is suggested for patients with severe disease. However, the factors associated with poor outcomes in these p
Externí odkaz:
https://doaj.org/article/edb53467678e48a6994894e9d63735a5
Autor:
Hsiao-Hui Chiu, Shih-Lin Chang, Hao-Min Cheng, Tze-Fan Chao, Yenn-Jiang Lin, Li-Wei Lo, Yu-Feng Hu, Fa-Po Chung, Jo-Nan Liao, Ta-Chuan Tuan, Chin-Yu Lin, Ting-Yung Chang, Ling Kuo, Chih-Min Liu, Yung-Nan Tsai, Yu-Ting Huang, Yuh-Lih Chang, Ju-Chieh Wung, Shih-Ann Chen
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Treatment with oral anticoagulants (OACs) could prevent stroke in atrial fibrillation (AF), but side effects developed due to OACs may cause patients anxiety during decision making. This study aimed to investigate whether shared d
Externí odkaz:
https://doaj.org/article/9f4ec5bcf3fc400e9697e6e73704c812
Autor:
Sheng‐Fan Wang, Kuan‐Wei Huang, Yueh‐Ching Chou, Hsin‐Chen Lee, Po‐Kuei Wu, Wei‐Ming Chen, Giun‐Yi Hung, Yuh‐Lih Chang
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12354-12364 (2023)
Abstract Background Taiwanese patients frequently experience severe hepatotoxicity associated with high‐dose methotrexate (HD‐MTX) treatment, which interferes with subsequent treatment. Drug–drug interactions occur when MTX is used in combinati
Externí odkaz:
https://doaj.org/article/eb12191d75f54c50a48d7ab20451a643
Autor:
Ju-Chieh Wung, Chia-Chen Hsu, Chi-En Wang, Yaa-Hui Dong, Chia-Chieh Lin, Szu-Yu Wang, Shih-Lin Chang, Yuh-Lih Chang
Publikováno v:
Advances in Pharmacological and Pharmaceutical Sciences, Vol 2024 (2024)
Introduction. Pharmacokinetic studies have shown that rifampin reduces the levels of oral anticoagulants during the initiation of coadministration, raising concerns about an increased thrombotic risk, but there are limited comparative clinical outcom
Externí odkaz:
https://doaj.org/article/494e333b61d2433dbfe2582fd6504d39
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract The incidence rates and consequences of inappropriate dosing of glucose-lowering drugs remain limited in patients with chronic kidney disease (CKD). A retrospective cohort study was conducted to estimate the frequency of inappropriate dosing
Externí odkaz:
https://doaj.org/article/6d952ad702964c50afcb86d6e48ab69b
Autor:
Yi-Kai Wang, Ying-Wen Wang, Chia-Ling Lu, Yi-Hsiang Huang, Ming-Chih Hou, Yuh-Lih Chang, Wei-Ping Lee, Keng-Hsin Lan
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Worsened lipid profiles were observed in chronic hepatitis C (CHC) patients during direct-acting antivirals (DAAs) treatment, among which combination drugs confounded the effect of individual ingredient on lipid. Tenofovir alafenamide (TAF)
Externí odkaz:
https://doaj.org/article/456e7822dc584a5dbae2b17ff9ee264e
Publikováno v:
Heliyon, Vol 9, Iss 3, Pp e14456- (2023)
Background and objective: Patients with atrial fibrillation (AF) are prescribed oral anticoagulants for stroke prevention; however, no evidence indicates that the use of direct oral anticoagulants (DOACs) in the first few days after ischemic stroke (
Externí odkaz:
https://doaj.org/article/c85d9c648cbc444ba6a0bbd77fbaa62c
Autor:
Shih-Hsuan Chao, Yuh-Lih Chang, Jiin-Cherng Yen, Hsien-Tzung Liao, Tsai-Hung Wu, Chia-Li Yu, Chang-Youh Tsai, Yueh-Ching Chou
Publikováno v:
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-14 (2020)
Abstract Background The efficacy and safety of rituximab (RTX) on hemolytic anemia (HA) is unknown. Therefore we retrospectively analyze the efficacy and safety of RTX in autoimmune hemolytic anemia (AIHA) and microangiopathic hemolytic anemia (MAHA)
Externí odkaz:
https://doaj.org/article/3678aa41f3ff45388c49c0bd325bf6fd
Autor:
Ju-Chieh Wung, Hsin-Chung Lin, Chia-Chen Hsu, Chia-Chieh Lin, Szu-Yu Wang, Shih-Lin Chang, Yuh-Lih Chang
Publikováno v:
PLoS ONE, Vol 17, Iss 8 (2022)
Drug-related problems (DRPs) in a pharmacist-managed anticoagulation clinic (AC) have not been extensively studied. We aimed to characterize the DRPs in a pharmacist-managed AC, identify the factors associated with the solved status of DRPs, and anal
Externí odkaz:
https://doaj.org/article/091443b091fc4a11835d147092ba5e14